The financial pressure on ambulatory surgery centers is no longer one story. It is several. A gastroenterology center, an orthopedic program and a cardiology ASC are all losing margin, but for reasons that barely overlap. That distinction matters, because a fix that rescues one specialty can be useless to another.
A July 2, 2026 analysis from Becker's ASC broke the cost crisis down service line by service line. For revenue cycle teams, the message is blunt. Across-the-board cost cutting will not save a center that is bleeding through specialty-specific channels. Precision will.
Here is where the money is leaking, and what it means for how specialty practices contract, code and collect.
Key Takeaways
Colonoscopy reimbursement has fallen more than 40% since 2001, and CMS applied a 2.5% work-RVU reduction to endoscopy and other non-time-based codes, per figures cited by Becker's.
Orthopedic implants remain among the highest-cost line items in an ASC and can exceed the total reimbursement for a case, according to a December 2025 Advantien report.
CMS added 276 procedures to the ASC covered procedures list for 2026, including cardiac catheter ablation, but commercial payer coverage has not kept pace.
The 2026 ASC conversion factor is $56.322 for centers meeting quality reporting, against $91.415 for hospital outpatient departments performing the same work.
UnitedHealthcare cut reimbursement 15% for CRNA services billed under the QZ modifier, effective October 1, 2025, in every state except seven.
Why Is Gastroenterology Losing Ground Even on High-Volume Cases?
Volume was supposed to be the shield. It is not holding. Colonoscopy reimbursement has dropped more than 40% since 2001, according to a Medscape report cited by Becker's, and CMS layered on a 2.5% reduction to work RVUs for endoscopy and other non-time-based codes, arguing efficiency gains that GI societies dispute.
The pay data tells the same story from a different angle. Average gastroenterologist compensation slipped from $512,000 in 2023 to $495,000 in 2024, a 3% nominal decline. Adjusted for inflation, GI procedure pay fell 33% between 2007 and 2022. Surinder Devgun, MD, of Rochester Gastroenterology Associates, described an inflection point where independent providers either take a pay cut, exit, or join a larger entity. For an RCM team, the lesson is that clean claims and disciplined contract review matter more than chasing one more case onto the schedule.
What Makes Orthopedic Costs So Hard to Control?
Orthopedics has the opposite problem. The pressure is on the supply side, and it does not negotiate. A December 2025 report from purchasing company Advantien found implants are regularly among the highest-cost items in an ASC and can sometimes exceed the total reimbursement for a procedure. The COVID-era spike in implant prices never fully reversed, and medical supply chain costs are projected to rise 2.41% in 2026.
Part of the problem is baked into how implants are priced. Mike Boblitz, CEO of Athens Orthopedic Clinic, told Becker's that rebate-driven pricing has inflated implant costs for years, rewarding centers for using higher-cost products. The revenue cycle response is specific. Detect underpayments before they age out, and make sure implant costs are captured and carved into payer contracts rather than quietly absorbed.
Why Are Newly Approved Cardiology Procedures Still Losing Money?
Cardiology is caught between a green light and an empty tank. For 2026, CMS added 276 procedures to the ASC covered procedures list, including cardiac catheter ablation and other cardiovascular and electrophysiology services. Approval is not payment. Commercial payers have been slow to price and contract for these cases in the outpatient setting.
The gap shows up as denials. Tracy Helmer, administrator of Tri-City Surgical Centers, told Becker's that his biggest payer issue is denials that do not line up with Medicare-payable procedures. His example is telling. Loop recorder implants are commonly denied by private payers for no prior authorization, even though the Medicare fee schedule requires none. A Medicare rule does not predict a commercial one, and cardiology RCM teams have to track prior authorization payer by payer to keep those cases from turning into write-offs.
How Big Is the Structural Gap Between ASCs and Hospitals?
Underneath every specialty sits one uncomfortable number. For 2026, the ASC conversion factor is $56.322 for centers meeting quality reporting requirements. For hospital outpatient departments, it is $91.415. Same procedure, sharply different facility payment. That gap is a standing argument for taking site-of-service economics seriously and for benchmarking every commercial contract against what the work actually costs to deliver.
Is Anesthesia the Cost Every Specialty Now Shares?
Yes, and it is the one line item that cuts across GI, orthopedics and cardiology alike. UnitedHealthcare cut reimbursement 15% for CRNA services billed under the QZ modifier, the code that signals care delivered without physician medical direction. The change took effect October 1, 2025 in every state except seven: Arkansas, California, Colorado, Hawaii, Massachusetts, New Hampshire and Wyoming. The insurer also stopped counting the P3, P4 and P5 physical status modifiers in its payment calculation. In many markets, centers now cover the difference with anesthesia stipends. Modeling that subsidy, and confirming modifiers are handled correctly on every claim, is now part of protecting the bottom line.
What This Means for Your Practice
The common thread is simple and unforgiving. Reimbursement is flat or falling while the cost to earn it keeps climbing. The centers holding their margins are the ones that stopped treating the revenue cycle as a back office and started treating it as a margin lever.
That means renegotiating per-CPT rates with current cost data, catching underpayments before they age, and tracking prior authorization rules one payer at a time. Cosentus does this work for orthopedics, wound care, pain management, anesthesia, behavioral health, ASCs and cardiology, and the approach is built around the pressures specific to each specialty rather than a single generic playbook.
Frequently Asked Questions
Does the 15% CRNA cut apply to my center?
It applies to CRNA services billed under the QZ modifier, which signals care delivered without physician medical direction, effective October 1, 2025. UnitedHealthcare excluded seven states: Arkansas, California, Colorado, Hawaii, Massachusetts, New Hampshire and Wyoming. It also stopped counting the P3, P4 and P5 physical status modifiers in the payment calculation.
CMS added hundreds of procedures to the ASC list. Why can't I just perform them?
Medicare approving a procedure for the ASC setting does not obligate commercial payers to cover or price it there. CMS added 276 procedures to the 2026 ASC covered procedures list, but private payer coverage and rates often lag, and some services are denied for prior-authorization reasons that do not apply under Medicare.
If colonoscopy pay keeps falling, does more volume fix it?
Not reliably. When rates erode faster than volume can compensate, the math turns against smaller practices. Contract discipline and denial prevention protect more revenue than raw case count.
What is the single most useful RCM change for a squeezed ASC?
Treat payer contracts as living documents and pair that with underpayment detection. Most centers leave recoverable dollars in improper denials and silent underpayments.
Where can I get help modeling this for my specialty?
Cosentus builds revenue cycle strategy around specialty-specific pressures. Reach us at cosentus.com/contact or (800) 378-0049.
Talk to Cosentus
Cost pressure is not going to ease on its own, and it will not hit two specialties the same way. If you want a revenue cycle built around the specific leaks in your service line, talk to Cosentus. Visit cosentus.com/contact or call (800) 378-0049.